AFMD: Affimed NV Sotuvning sof marjinal rentabelligi

AFMD (Affimed NV) - kompaniyaning tovar belgisi

Sotuv marjasi dinamikasi Affimed (AFMD) ga nisbatan bozor kutganlarini aks ettiradi, bunda 0.00 ko'rsatkichning joriy qiymatini ifodalaydi. Yuqori daromadlilik komponentlar ta'minot zanjirlarini optimallashtirish orqali ta'minlanmoqda. Onkologik xatarlar turli limfomalar uchun terapiyalarni ishlab chiqish orqali yumshatilmoqda. Shu bilan birga, Affimed (AFMD) yirik korporativ texnologik gigantlar kirishidan oldin bozor ulushini egallashni maqsad qilgan holda, o'zining klinik sinovlarini jadallashtirmoqda.

Affimed N.V. (AFMD) - Kompaniya sotuv marjasi 04.07.2022dan 31.05.2025gacha

Affimed kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning jamlanma tahlili:Affimed Therapeutics - AFMD
Affimed yetakchi tovari

Affimed (AFMD) uchun kompaniyaning sof marja profili tushumni sof foydaga aylantirish samaradorligini aks ettiradi. Ushbu metrika hisobot vaqtidagi kechikishlarni hisobga olmagan holda, mahsulotning har bir birligidan olinadigan foyda ulushini o'lchaydi. Ushbu ko'rsatkichning yuqori sezuvchanligi kapitalni boshqarish sifatini va aktiv uchun haddan tashqari ko'p to'lov qilish xavfini ochib beradi. Ushbu immunoterapiya ishlab chiquvchisi uchun bu juda muhimdir: ulkan klinik xarajatlar ommaviy ishlab chiqarishning past xarajatlari bilan almashiladi. Egri chiziq tendentsiyasi biznesning monopol superfoyda olish qobiliyatini tasdiqlaydi.

Raqobatchilar tahlili

argenx (ARGX) - Sof marja|BNTX - Kompaniya sotuv marjasi|ABVX (Abivax Pharma) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ADMA Bio (ADMA)|Sof foyda bo'yicha sotuv rentabelligi PTGX (Protagonist Therapeutics Inc)|Sotuvning sof marjinal rentabelligi immunovant.com (IMVT)|Sof marja kiniksa.com KNSA|Grifols SA (GRFS) - Sof marja|Adaptive Biotechnologies Inc. - Sotuvning sof marjinal rentabelligi|Sof marja Celldex Therapeutics|AUPH: Sotuvning sof marjinal rentabelligi|BCRX - Kompaniya sotuv marjasi|VERA (Vera Corp) - Sotuvning sof marjinal rentabelligi|Dianthus Pharma (DNTH) - Kompaniya sotuv marjasi|Sof marja Pharvaris Pharma (PHVS)|Sotuvning sof marjinal rentabelligi AbCellera Corp (ABCL)|Sotuvning sof marjinal rentabelligi TRML (Tourmaline Bio Inc)|Kompaniya sotuv marjasi precigen.com (PGEN)|PHAR - Sof marja|Sof foyda normasi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Sof foyda bo'yicha sotuv rentabelligi|Zenas Corp (ZBIO) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi IMNM|GOSS: Sof foyda normasi|Sof marja KalVista Pharma (KALV)|SEPN - Sof marja|Sotuvning sof marjinal rentabelligi PVLA (pieris.com)|Sotuvning sof marjinal rentabelligi Savara Pharma SVRA|RIGL: Sof foyda bo'yicha sotuv rentabelligi|ANAB - Sotuvning sof marjinal rentabelligi|ATXS: Sotuvning sof marjinal rentabelligi|ENGN - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi RAPT|JBIO (Aerovate Therapeutics Inc) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi ACRS|Sof foyda bo'yicha sotuv rentabelligi kyvernatx.com KYTX|Sotuvning sof marjinal rentabelligi TLSA (Tiziana Life Sciences, Ltd.)|Sotuvning sof marjinal rentabelligi Cabaletta Bio CABA|VTYX: Sof foyda bo'yicha sotuv rentabelligi|Theratechnologies Inc. (THTX) - Sof foyda bo'yicha sotuv rentabelligi|AVTX: Sotuvning sof marjinal rentabelligi|ELDN - Kompaniya sotuv marjasi|AGEN (Agenus, Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi Climb Bio, Inc.|Sof marja Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi ADAG (Adagene Inc)|IMA - Sof foyda bo'yicha sotuv rentabelligi|STTK - Sof marja|EQ (equilliumbio.com) - Sotuvning sof rentabelligi|CNTB: Sotuvning sof marjinal rentabelligi|Immunic Inc (IMUX) - Sotuvning sof marjinal rentabelligi|ATRA (Atara Biotherapeutics Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Sof foyda normasi|Adicet Bio, Inc. - Sotuvning sof rentabelligi|Celularity Inc - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi INmune Bio Corporation INMB|Barinthus Biotherapeutics - Sotuvning sof marjinal rentabelligi|Kezar Life Sciences, Inc. (KZR) - Sof foyda bo'yicha sotuv rentabelligi|SAB Biotherapeutics Inc. (SABS) - Sof marja|Sof foyda bo'yicha sotuv rentabelligi Akari Therapeutics plc|Sof marja enlivex.com|q32bio.com (QTTB) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi GOVX|Edesa Biotech, Inc. - Sotuvning sof rentabelligi|iBio Inc - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Carisma Therapeutics CARM|XTLB - Sof marja|BOLT (boltbio.com) - Sotuvning sof rentabelligi|HCWB: Sotuvning sof marjinal rentabelligi|Aptevo (APVO) - Sotuvning sof marjinal rentabelligi|Sof marja AIM ImmunoTech|Sof foyda bo'yicha sotuv rentabelligi Aditxt (ADTX)|Sof foyda bo'yicha sotuv rentabelligi GRI (GRI Bio Corporation)|XORTX - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi HIND (Vyome Holdings Inc.)|Sof foyda normasi REVB|Indaptus - Sotuvning sof marjinal rentabelligi|SCNI (Scinai Immunotherapeutics Ltd.) - Sotuvning sof rentabelligi|CALI: Sotuvning sof marjinal rentabelligi|Allakos Therapeutics (ALLK) - Sotuvning sof marjinal rentabelligi|HOOK (HOOKIPA) - Sotuvning sof marjinal rentabelligi|igmbio.com (IGMS) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi ITOS|OCEA (Ocean Biomedical) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi TCBP (TC BioPharm (Holdings) PLC)|THRD - Sof foyda bo'yicha sotuv rentabelligi